Private Capital Group, LLC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 224 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.

Quarter-by-quarter ownership
Private Capital Group, LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$8,000
-11.1%
263
-6.4%
0.01%
+200.0%
Q1 2022$9,000
+28.6%
281
+23.2%
0.00%
+100.0%
Q4 2021$7,000
+16.7%
228
+2.7%
0.00%0.0%
Q3 2021$6,000
-25.0%
222
-17.8%
0.00%
-50.0%
Q2 2021$8,0000.0%270
-14.8%
0.00%0.0%
Q1 2021$8,000
+100.0%
317
+84.3%
0.00%
+100.0%
Q4 2020$4,000
-20.0%
172
-29.8%
0.00%0.0%
Q3 2020$5,000
+25.0%
245
+33.9%
0.00%0.0%
Q2 2020$4,0000.0%183
-25.0%
0.00%0.0%
Q1 2020$4,000
-50.0%
244
-32.6%
0.00%
-50.0%
Q4 2019$8,000
-20.0%
362
+3.1%
0.00%0.0%
Q3 2019$10,000
-88.0%
351
-74.5%
0.00%
-89.5%
Q2 2019$83,000
+260.9%
1,379
+108.0%
0.02%
+375.0%
Q1 2019$23,000
-20.7%
663
-24.5%
0.00%
-33.3%
Q4 2018$29,000
-44.2%
878
-16.2%
0.01%
-40.0%
Q3 2018$52,000
-36.6%
1,048
-24.0%
0.01%
-44.4%
Q2 2018$82,000
+54.7%
1,379
+18.5%
0.02%
+50.0%
Q1 2018$53,000
+17.8%
1,164
+3.2%
0.01%
+9.1%
Q4 2017$45,0001,1280.01%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
HealthInvest Partners AB 335,000$8,934,00013.38%
ASHFORD CAPITAL MANAGEMENT INC 1,016,665$27,114,0002.46%
Bruce & Co., Inc. 402,105$10,724,0002.28%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 297,500$7,934,0001.91%
ARMISTICE CAPITAL, LLC 3,900,000$104,013,0001.76%
Bridge City Capital, LLC 108,884$2,904,0001.32%
S&T BANK/PA 316,098$8,430,0001.31%
Kent Lake Capital LLC 100,000$2,667,0001.15%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 331,140$8,832,0001.02%
Prairiewood Capital, LLC 45,297$1,208,0000.99%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders